These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15635420)

  • 1. New patent rules drive Indian drug firms to research.
    Jayaraman KS
    Nat Med; 2005 Jan; 11(1):3. PubMed ID: 15635420
    [No Abstract]   [Full Text] [Related]  

  • 2. Firms discovering reality of clinical research in India.
    Jayaraman KS
    Nat Rev Drug Discov; 2006 Jan; 5(1):6. PubMed ID: 16485338
    [No Abstract]   [Full Text] [Related]  

  • 3. Today's biotech industry in India.
    Suresh N
    Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
    [No Abstract]   [Full Text] [Related]  

  • 4. [Novartis should discontinue its patent case in India!].
    PehrOlov P
    Lakartidningen; 2007 Feb 14-20; 104(7):524. PubMed ID: 17375688
    [No Abstract]   [Full Text] [Related]  

  • 5. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

  • 7. India moves gently to liberalize drug industry.
    Jayaraman KS
    Nature; 1994 Sep; 371(6492):8. PubMed ID: 8072531
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarbanes-Oxley rules to be relaxed?
    Lawrence S
    Nat Biotechnol; 2006 Jul; 24(7):731-2. PubMed ID: 16841042
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharma industry in India.
    Sundaram VM
    Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues in Indian science.
    Byravan S
    Science; 2005 Jul; 309(5734):557-8; author reply 557-8. PubMed ID: 16044529
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the rules now governing Italy's drug industry.
    Dompé S
    Nature; 2008 Aug; 454(7208):1049. PubMed ID: 18756232
    [No Abstract]   [Full Text] [Related]  

  • 15. The Indian and Chinese health biotechnology industries: potential champions of global health?
    Frew SE; Kettler HE; Singer PA
    Health Aff (Millwood); 2008; 27(4):1029-41. PubMed ID: 18607038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 17. Entering the contract research industry in India.
    Joseph J
    Contemp Clin Trials; 2008 May; 29(3):311-3. PubMed ID: 18053773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conducting pharmaceutical R&D in India - Critical components of entry strategies.
    Gulati R
    IDrugs; 2008 Nov; 11(11):817-22. PubMed ID: 18988126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 20. Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to India.
    Sinha G
    Sci Am; 2004 Aug; 291(2):24-5. PubMed ID: 15298112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.